Trials that use: Multiple imputation / missing data
New to this method? Read the tutorial →
9,924 results
- Gemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or Sézary Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Gemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or Sézary Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer: Complete Statistical AnalysisIndependent statistical analysis of Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer: primary endpoint results, effect estimate with confidence…
- Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma: Complete Statistical AnalysisIndependent statistical analysis of Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery: Complete Statistical AnalysisIndependent statistical analysis of Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery: primary endpoint results, effect estimate with confidence interval,…
- Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval,…
- Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Gemcitabine/Taxotere/Xeloda (GTX) With Cisplatin in Subjects With Metastatic Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Gemcitabine/Taxotere/Xeloda (GTX) With Cisplatin in Subjects With Metastatic Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01459614).
- GEMINIIndependent statistical analysis of A Safety Study of Retinal Gene Therapy for Choroideremia With Administration of BIIB111: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- GEMINI LTSIndependent statistical analysis of An Open-label Study of Vedolizumab (MLN0002) in Participants With Ulcerative Colitis and Crohn's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- GEMINI Study – A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection: Complete Statistical AnalysisIndependent statistical analysis of GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Gene Expression in Renal Transplant Patients With Field Actinic Keratosis Undergoing Metvix® Photodynamic Therapy (PDT): Complete Statistical AnalysisIndependent statistical analysis of Gene Expression in Renal Transplant Patients With Field Actinic Keratosis Undergoing Metvix® Photodynamic Therapy (PDT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Gene Signatures of Influenza Vaccine Responses in Older Adults: Complete Statistical AnalysisIndependent statistical analysis of Gene Signatures of Influenza Vaccine Responses in Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03603509).
- Gene Therapy for X-linked Retinitis Pigmentosa (XLRP) – Retinitis Pigmentosa GTPase Regulator (RPGR): Complete Statistical AnalysisIndependent statistical analysis of Gene Therapy for X-linked Retinitis Pigmentosa (XLRP) - Retinitis Pigmentosa GTPase Regulator (RPGR): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD: Complete Statistical AnalysisIndependent statistical analysis of Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- General Anesthesia With ETT vs LMA in Patients Undergoing Ablation for Atrial Fibrillation: Complete Statistical AnalysisIndependent statistical analysis of General Anesthesia With ETT vs LMA in Patients Undergoing Ablation for Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- GENERATIONIndependent statistical analysis of Saxagliptin Compared to Glimepiride in Elderly Type 2 Diabetes Patients, With Inadequate Glycemic Control on Metformin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Genes, Fibrinolysis and Endothelial Dysfunction- Dialysis Aim 3: Complete Statistical AnalysisIndependent statistical analysis of Genes, Fibrinolysis and Endothelial Dysfunction- Dialysis Aim 3: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00878969).
- Genetic and Brain Mechanisms of Naltrexone’s Treatment Efficacy for Alcoholism: Complete Statistical AnalysisIndependent statistical analysis of Genetic and Brain Mechanisms of Naltrexone's Treatment Efficacy for Alcoholism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00920829).
- Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy: Complete Statistical AnalysisIndependent statistical analysis of Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Genetic and Neural Factors in Alcohol-Related Cognition: Complete Statistical AnalysisIndependent statistical analysis of Genetic and Neural Factors in Alcohol-Related Cognition: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03725345).
- Genetic Basis for Variation in the Renal Elimination of Metformin: Complete Statistical AnalysisIndependent statistical analysis of Genetic Basis for Variation in the Renal Elimination of Metformin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00187720).
- Genetic Effects on Dopamine Response to an Opiate: Complete Statistical AnalysisIndependent statistical analysis of Genetic Effects on Dopamine Response to an Opiate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01878006).
- Genetically Determined Response to Atenolol in Patients With Persistent Atrial Fibrillation: Complete Statistical AnalysisIndependent statistical analysis of Genetically Determined Response to Atenolol in Patients With Persistent Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas: Complete Statistical AnalysisIndependent statistical analysis of Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Geniculate Artery Embolization for Knee Pain Secondary to Osteoarthritis (OA): Complete Statistical AnalysisIndependent statistical analysis of Geniculate Artery Embolization for Knee Pain Secondary to Osteoarthritis (OA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03362957).
- GeniProIndependent statistical analysis of Genistein Supplementation to Mitigate Cardiometabolic Dysfunction in Patients Undergoing Androgen Deprivation Therapy for Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Genomic Markers Before and After Treatment of Actinic Keratosis With Imiquimod 3.75% Cream: Complete Statistical AnalysisIndependent statistical analysis of Genomic Markers Before and After Treatment of Actinic Keratosis With Imiquimod 3.75% Cream: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Genotype-supported Versus Conventional Proton Pump Inhibitor Dosing: Complete Statistical AnalysisIndependent statistical analysis of Genotype-supported Versus Conventional Proton Pump Inhibitor Dosing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02930824).
- Gentamicin Bladder Instillations to Prevent Urinary Tract Infections in Patients With Spinal Cord Injury: Complete Statistical AnalysisIndependent statistical analysis of Gentamicin Bladder Instillations to Prevent Urinary Tract Infections in Patients With Spinal Cord Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- GeoScan and Remote Geo Smoking Study: Neural and Behavioral Correlates of Smokers’ Exposure to Retail Environments: Complete Statistical AnalysisIndependent statistical analysis of GeoScan and Remote Geo Smoking Study: Neural and Behavioral Correlates of Smokers' Exposure to Retail Environments: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Geriatric Ketamine for Pain Management Study: Complete Statistical AnalysisIndependent statistical analysis of Geriatric Ketamine for Pain Management Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02673372).
- Gestational Weight Gain and Postpartum Weight Loss in Active Duty Women (Moms Fit 2 Fight): Complete Statistical AnalysisIndependent statistical analysis of Gestational Weight Gain and Postpartum Weight Loss in Active Duty Women (Moms Fit 2 Fight): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- GETGOAL-L-ASIAIndependent statistical analysis of GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin +/- Sulfonylurea (GETGOAL-L-ASIA): primary endpoint results, effect…
- GETGOAL-MONOIndependent statistical analysis of GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- GETUGV04Independent statistical analysis of A Phase II Trial Evaluating an Organ-conserving Strategy by Radiochemotherapy for Muscle-infiltrative Bladder Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- GIANTIndependent statistical analysis of Phase 4 Study to Assess the Effect of Bisoprolol on Glycemic Level in Type II Diabetic Subjects With Suboptimal Blood Pressure Control: primary endpoint results, effect estimate with…
- GINGERIndependent statistical analysis of Ginger's Therapeutic Potential in Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03705832).
- Gingival Crevicular Fluid Characterization During Orthodontic Treatment: Complete Statistical AnalysisIndependent statistical analysis of Gingival Crevicular Fluid Characterization During Orthodontic Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04226469).
- Girls on the Move Intervention to Increase Physical Activity Among Middle School Girls: Complete Statistical AnalysisIndependent statistical analysis of Girls on the Move Intervention to Increase Physical Activity Among Middle School Girls: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency: Complete Statistical AnalysisIndependent statistical analysis of Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- GLEAMIndependent statistical analysis of A Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME): primary endpoint results, effect estimate with confidence…
- Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma: Complete Statistical AnalysisIndependent statistical analysis of Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma: primary endpoint results, effect estimate with confidence interval, sample-size…
- GLIDERIndependent statistical analysis of A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Primary Sjögren's Syndrome (pSS): primary endpoint results, effect estimate…
- GlideScope Versus Direct Laryngoscope for Emergency Intubation: Complete Statistical AnalysisIndependent statistical analysis of GlideScope Versus Direct Laryngoscope for Emergency Intubation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01235065).
- GlideScope Video Laryngoscope Versus Fiberoptic Intubation: Complete Statistical AnalysisIndependent statistical analysis of GlideScope Video Laryngoscope Versus Fiberoptic Intubation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01091948).
- GlideScope®Video Laryngoscope for Difficult Intubation: Implication of the Size of Blade: Complete Statistical AnalysisIndependent statistical analysis of GlideScope®Video Laryngoscope for Difficult Intubation: Implication of the Size of Blade: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Glimepiride 4 mg Tablets Under Non-Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of Glimepiride 4 mg Tablets Under Non-Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00835172).